Who will takeover BMS?

Discussion in 'Bristol-Myers Squibb' started by Aristotle, Feb 14, 2017 at 10:03 PM.

Tags: Add Tags
?

Who will takeover BMS?

Poll closed May 15, 2017.
  1. Roche

    0 vote(s)
    0.0%
  2. Novartis

    0 vote(s)
    0.0%
  3. Pfizer

    0 vote(s)
    0.0%
  4. Gilead

    0 vote(s)
    0.0%
  5. Neither

    0 vote(s)
    0.0%
  1. Aristotle

    Aristotle Guest

    Coming Summer 2017.
     

  2. anonymous

    anonymous Guest

    Pfizer- gets all of Eliquis and badly needed cancer biologics. Shutdown all NJ sites.
     
  3. anonymous

    anonymous Guest

    That sounds plausible. It seems like it's the end of the road for BMS. Poor senior management
     
  4. anonymous

    anonymous Guest

    Pfizer
     
  5. anonymous

    anonymous Guest

    Purdue<Horizon<Turing
     
  6. anonymous

    anonymous Guest

    Jimmy Johns
     
  7. anonymous

    anonymous Guest

    Can't wait to see how the Italian and Canadian mafia survive (likely not) in proper pharma.
     
  8. anonymous

    anonymous Guest

    Pfizer selling its HQ, nice new offices in PPK......shouldn't put two and two together really but .......it is fun!!!
     
  9. anonymous

    anonymous Guest

    The "lifers" you mean? I bet there are some twitching rings out there wondering how quickly they'll get found out...
     
  10. anonymous

    anonymous Guest

    it wont be jimmy johns because we are not freaky fast
     
  11. anonymous

    anonymous Guest

    Time to update your resume' and get out there...it's coming!
     
  12. anonymous

    anonymous Guest

    Amazon orWalmart.better management
     
  13. anonymous

    anonymous Guest


    Lol ....
     
  14. anonymous

    anonymous Guest

    The pharma sales force market across the industry continues to contract. You better pray that whoever buys BMS needs 60% of the sales force. If it is Roche, no need for duplicate oncology reps. Should it be Pfizer, no need for duplicate cardio reps,.......
    You're saving grace would be Gilead buying you, then it would just be the out-of-date HIV sent to pasture.
     
  15. anonymous

    anonymous Guest

    Step up to the plate Buyers, any and all are welcome .. the bidding starts at 100 billion but dont expect to get it that cheap .

    .21 oncology drugs in the pipeline to go with opdivo which is already a multi billion dollar drug..

    A brand new state of the art building

    Gilead is a desperate company with 0 pipeline so if they will pay 110 billion They can go for it.. they are a one trick pony with an overpriced medicine

    I have plenty of bmy stock and options so let's go!!!
     
  16. anonymous

    anonymous Guest

    Gilead ... They have nothing except money !
     
  17. anonymous

    anonymous Guest

    let me start the bidding.......100.00 and none of your reps.
     
  18. anonymous

    anonymous Guest

    You are clearly ill informed of Gilead and their pipeline. Time to actually do some reading. And NO, they won't keep you.
     
  19. anonymous

    anonymous Guest

    CV reps, DBMs and RBDs- time to update your resumes.
     
  20. anonymous

    anonymous Guest

    Blah Blah fuckin Blah! Been hearing this for years!